Mountain gorillas are the global superstars among the world’s great apes. They rose to fame following their memorable encounter with David Attenborough, vice-president of Fauna & Flora since 1979, ...

For example, you can use stock scanners like Magnifi and Interactive Brokers to filter stocks by industry, price, the average number of shares that change hands during a day and more. Stock ...

After all, just about everyone has used Adobe Acrobat Reader for opening a PDF at some point. The platform allows you to create PDFs from just about everywhere: Microsoft Office applications ...

The e-reader market is dominated by Amazon with its Kindle and Rakuten with its Kobo. We've tested the latest generation of e-readers from both manufacturers, along with some older alternative models ...

The paperwhite is the best balance of advanced features and reasonable price of any Kindle, or any other ebook reader. Unlike other Kindles, this one uses a newer type of e-ink, which offers a ...

Whether you need to scan family photos, piles of documents, or expense receipts, a scanner out there is built for the task. Here's how to shop for the right one, plus the top performers in our lab ...

The upward trajectory continues for Eikon Therapeutics, which announced that it has raised $351 million to fund various cancer related clinical trials. The Series D funding unveiled Wednesday morning ...

The Trump administration is pushing migrants to be fingerprinted for a new registry of people illegally in the United States, the Department of Homeland Security (DHS) announced late Tuesday.

One of biotech’s best-fund­ed star­tups has just raised a huge new round to take its lead drug in­to fi­nal-stage test­ing.

Eikon Therapeutics is no stranger to eye-popping funding rounds, and the cancer-focused biotech has continued this trend with a $350.7 million series D to fuel its various clinical trials.

HAYWARD, Calif., February 26, 2025--(BUSINESS WIRE)--Eikon Therapeutics, Inc., a pivotal-stage biotechnology company that integrates advanced engineering with cutting-edge molecular and cell ...

To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Eikon Therapeutics, a well-funded drug startup run by Merck & Co.’s former research chief, has raised ...